22 May 2013
Keywords: exelixis, plans, start, clinical, trials, xl647, usa-based
Article | 01 March 2004
USA-based Exelixis has submitted an Investigational New Drug application with the US Food and Drug Administration for XL647, a potential
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 March 2004
21 May 2013
© 2013 thepharmaletter.com